GlassScriptPhysician profile
Mark A Greenberg
NPI 1376628149
$2,944.25
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $395 · 2021: $704 · 2022: $597 · 2023: $916 · 2024: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $535.98 | 2019-2023 | Avvigo Guidance System |
| Shockwave Medical, INC | $527.30 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $391.60 | 2020-2023 | Optis |
| Terumo Medical Corporation | $335.59 | 2022-2023 | Glidewire, Glidesheath Slender, Metacross Otw |
| Medtronic, INC. | $321.99 | 2022-2023 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $315.49 | 2020 | |
| Abiomed | $183.73 | 2019-2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $159.82 | 2019-2021 | |
| Chiesi USA, INC. | $74.35 | 2020-2021 | |
| Penumbra, INC. | $45.73 | 2021-2022 | |
| Amgen INC. | $29.25 | 2020 | |
| Janssen Pharmaceuticals, INC | $23.42 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.